LARYNG-O-JET KIT

Post-LOE

lidocaine hydrochloride

Medica Corp

ANDATOPICALSOLUTION

Approved

Mar 1980

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

LARYNG-O-JET KIT (lidocaine hydrochloride) by Medica Corp is clinical pharmacology mechanism of action: lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action. Approved for regional anesthesia, analgesia for surgery, dental and 4 more indications. First approved in 1980.

Drug data last refreshed 19h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Mechanism of Action: Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action. The onset of action is rapid. Hemodynamics: Excessive blood levels may cause…

Worked on LARYNG-O-JET KIT at Medica Corp? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

LARYNG-O-JET KIT

Mechanism of Action

Indications (7)

Clinical Trials (1)